Cargando…
Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation
AIMS: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318394/ https://www.ncbi.nlm.nih.gov/pubmed/36869774 http://dx.doi.org/10.1093/cvr/cvad037 |
_version_ | 1785068027883028480 |
---|---|
author | Funk, Florian Kronenbitter, Annette Hackert, Katarzyna Oebbeke, Matthias Klebe, Gerhard Barth, Mareike Koch, Daniel Schmitt, Joachim P |
author_facet | Funk, Florian Kronenbitter, Annette Hackert, Katarzyna Oebbeke, Matthias Klebe, Gerhard Barth, Mareike Koch, Daniel Schmitt, Joachim P |
author_sort | Funk, Florian |
collection | PubMed |
description | AIMS: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can inhibit SERCA2a by direct interaction, the functional role of pentamers is still unclear. This study investigates the functional consequences of PLN pentamerization. METHODS AND RESULTS: We generated transgenic mouse models expressing either a PLN mutant that cannot form pentamers (TgAFA-PLN) or wild-type PLN (TgPLN) in a PLN-deficient background. TgAFA-PLN hearts demonstrated three-fold stronger phosphorylation of monomeric PLN, accelerated Ca(2+) cycling of cardiomyocytes, and enhanced contraction and relaxation of sarcomeres and whole hearts in vivo. All of these effects were observed under baseline conditions and abrogated upon inhibition of protein kinase A (PKA). Mechanistically, far western kinase assays revealed that PLN pentamers are phosphorylated by PKA directly and independent of any subunit exchange for free monomers. In vitro phosphorylation of synthetic PLN demonstrated that pentamers even provide a preferred PKA substrate and compete with monomers for the kinase, thereby reducing monomer phosphorylation and maximizing SERCA2a inhibition. However, β-adrenergic stimulation induced strong PLN monomer phosphorylation in TgPLN hearts and sharp acceleration of cardiomyocyte Ca(2+) cycling and haemodynamic values that now were indistinguishable from TgAFA-PLN and PLN-KO hearts. The pathophysiological relevance of PLN pentamerization was evaluated using transverse aortic constriction (TAC) to induce left ventricular pressure overload. Compared to TgPLN, TgAFA-PLN mice demonstrated reduced survival after TAC, impaired cardiac haemodynamics, failure to respond to adrenergic stimulation, higher heart weight, and increased myocardial fibrosis. CONCLUSIONS: The findings show that PLN pentamerization greatly impacts on SERCA2a activity as it mediates the full range of PLN effects from maximum inhibition to full release of SERCA2a function. This regulation is important for myocardial adaptation to sustained pressure overload. |
format | Online Article Text |
id | pubmed-10318394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103183942023-07-05 Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation Funk, Florian Kronenbitter, Annette Hackert, Katarzyna Oebbeke, Matthias Klebe, Gerhard Barth, Mareike Koch, Daniel Schmitt, Joachim P Cardiovasc Res Original Article AIMS: A key event in the regulation of cardiac contraction and relaxation is the phosphorylation of phospholamban (PLN) that relieves the inhibition of the sarco/endoplasmic reticulum (SR) Ca(2+)-ATPase (SERCA2a). PLN exists in an equilibrium between monomers and pentamers. While only monomers can inhibit SERCA2a by direct interaction, the functional role of pentamers is still unclear. This study investigates the functional consequences of PLN pentamerization. METHODS AND RESULTS: We generated transgenic mouse models expressing either a PLN mutant that cannot form pentamers (TgAFA-PLN) or wild-type PLN (TgPLN) in a PLN-deficient background. TgAFA-PLN hearts demonstrated three-fold stronger phosphorylation of monomeric PLN, accelerated Ca(2+) cycling of cardiomyocytes, and enhanced contraction and relaxation of sarcomeres and whole hearts in vivo. All of these effects were observed under baseline conditions and abrogated upon inhibition of protein kinase A (PKA). Mechanistically, far western kinase assays revealed that PLN pentamers are phosphorylated by PKA directly and independent of any subunit exchange for free monomers. In vitro phosphorylation of synthetic PLN demonstrated that pentamers even provide a preferred PKA substrate and compete with monomers for the kinase, thereby reducing monomer phosphorylation and maximizing SERCA2a inhibition. However, β-adrenergic stimulation induced strong PLN monomer phosphorylation in TgPLN hearts and sharp acceleration of cardiomyocyte Ca(2+) cycling and haemodynamic values that now were indistinguishable from TgAFA-PLN and PLN-KO hearts. The pathophysiological relevance of PLN pentamerization was evaluated using transverse aortic constriction (TAC) to induce left ventricular pressure overload. Compared to TgPLN, TgAFA-PLN mice demonstrated reduced survival after TAC, impaired cardiac haemodynamics, failure to respond to adrenergic stimulation, higher heart weight, and increased myocardial fibrosis. CONCLUSIONS: The findings show that PLN pentamerization greatly impacts on SERCA2a activity as it mediates the full range of PLN effects from maximum inhibition to full release of SERCA2a function. This regulation is important for myocardial adaptation to sustained pressure overload. Oxford University Press 2023-03-03 /pmc/articles/PMC10318394/ /pubmed/36869774 http://dx.doi.org/10.1093/cvr/cvad037 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Funk, Florian Kronenbitter, Annette Hackert, Katarzyna Oebbeke, Matthias Klebe, Gerhard Barth, Mareike Koch, Daniel Schmitt, Joachim P Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
title | Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
title_full | Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
title_fullStr | Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
title_full_unstemmed | Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
title_short | Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
title_sort | phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318394/ https://www.ncbi.nlm.nih.gov/pubmed/36869774 http://dx.doi.org/10.1093/cvr/cvad037 |
work_keys_str_mv | AT funkflorian phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT kronenbitterannette phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT hackertkatarzyna phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT oebbekematthias phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT klebegerhard phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT barthmareike phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT kochdaniel phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation AT schmittjoachimp phospholambanpentamerizationincreasessensitivityanddynamicrangeofcardiacrelaxation |